×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [34]
内容类型
期刊论文 [22]
会议论文 [12]
发表日期
2019 [2]
2018 [3]
2017 [5]
2016 [1]
2015 [5]
2014 [3]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共34条,第1-10条
帮助
限定条件
专题:复旦大学上海医学院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Establishment and characterization of a patient-derived circulating lung tumor cell line in vitro and in vivo
期刊论文
CANCER CELL INTERNATIONAL, 2019, 卷号: 19
作者:
Que, Zujun
;
Luo, Bin
;
Zhou, Zhiyi
;
Dong, Changsheng
;
Jiang, Yi
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2019/12/05
Non-small cell lung cancer
Circulating tumor cell
Metastasis
Organ colonization
Prevention
Weekly albumin-bound paclitaxel/cisplatin versus gemcitabine/cisplatin as first-line therapy for patients with advanced non-small-cell lung cancer: A phase II open-label clinical study
期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2019, 卷号: 31, 期号: 2
作者:
Wu, Xianghua
;
Qin, Shanshan
;
Yu, Hui
;
Luo, Zhiguo
;
Wang, Huijie
收藏
  |  
浏览/下载:28/0
  |  
提交时间:2019/12/05
Albumin-bound paclitaxel
cisplatin
gemcitabine
first-line therapy
advanced non-small-cell lung cancer
Maintenance Chemotherapy With Chinese Herb Medicine Formulas vs. With Placebo in Patients With Advanced Non-small Cell Lung Cancer After First-Line Chemotherapy: A Multicenter, Randomized, Double-Blind Trial
期刊论文
FRONTIERS IN PHARMACOLOGY, 2018, 卷号: 9
作者:
Wang, Qin
;
Jiao, Lijing
;
Wang, Shengfei
;
Chen, Peiqi
;
Bi, Ling
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/12/05
NSCLC
maintenance chemotherapy
chinese herb medicine formulas
adverse events
quality of life
Upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer
期刊论文
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 卷号: 155, 期号: 4
作者:
Zheng, Difan
;
Ye, Ting
;
Hu, Hong
;
Zhang, Yawei
;
Sun, Yihua
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2019/12/05
non-small cell lung cancer
stage IIIA
upfront surgery
progression free survival
overall survival
Factors associated with gene aberration test status and treatment decision in patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer: A multicenter survey in China (CTONG 1506)
期刊论文
LUNG CANCER, 2018, 卷号: 123
作者:
Song, Yong
;
Zhou, Qing
;
Zhang, Xin
;
Chen, Gong-Yan
;
Zhong, Dian-Sheng
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/12/05
Nonsquamous non-small cell lung cancer
Gene aberration test
First-line anticancer treatment
Real-world research
Tyrosine kinase inhibitor
Chemotherapy
A Randomized, Multi-Center, Double Blind Phase II Study of Fruquintinib in Patients with Advanced Non-Small Cell Lung Cancer
会议论文
作者:
Lu, Shun
;
Chang, Jianhua
;
Liu, Xiaoqing
;
Shi, Jianhua
;
Lu, You
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/12/05
non-small cell lung cancer
PROGRESSION FREE SURVIVAL
vascular endothelial growth factor receptor
third-line treatment
The role of weekly nanoparticle albumin bound paclitaxel monotherapy as second line or later treatment for advanced NSCLC in China
期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 50
作者:
Xing, Puyuan
;
Zhu, Yixiang
;
Shan, Ling
;
Chen, Sipeng
;
Hao, Xuezhi
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/05
advanced non-small cell lung cancer (NSCLC)
multiple treatments
taxane
nanoparticle albumin bound paclitaxel (Nab-PTX)
secreted protein acidic and rich in cysteine (SPARC)
A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506)
期刊论文
BMC CANCER, 2017, 卷号: 17
作者:
Zhou, Qing
;
Song, Yong
;
Zhang, Xin
;
Chen, Gong-Yan
;
Zhong, Dian-Sheng
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2019/12/05
Chemotherapy
China
Epidermal growth factor receptor
First-line anticancer treatment
Non-small cell lung cancer
Tyrosine kinase inhibitor
Efficacy and safety of Endostar (recombinant human endostatin hormone) combined with docetaxel as second-or third-line therapy for patients with non-small-cell lung cancer
期刊论文
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 卷号: 10, 期号: 1
作者:
Ji, Dongmei
;
Wang, Jialei
;
Yu, Hui
;
Wu, Xianghua
;
Wang, Huijie
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/12/05
Carcinoma
non-small-cell lung
chemotherapy
second or third line therapy
endostar protein
docetaxel
Efficacy and safety of first-line pemetrexed plus carboplatin followed by single-agent pemetrexed maintenance in elderly Chinese patients with non-squamous non-small-cell lung cancer
期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 49
作者:
Qiao, Jie
;
Zhao, Xinmin
;
Yu, Hui
;
Zhao, Jing
;
Wu, Xianghua
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/05
non-small-cell lung cancer
pemetrexed
carboplatin
elderly
maintenance therapy
©版权所有 ©2017 CSpace - Powered by
CSpace